KALV – kalvista pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KALV

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/4

08:05 am

kalv

KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.

High Report

KalVista Pharmaceuticals (NASDAQ:KALV) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.

Report

12/4

05:48 am

kalv

Rating for KALV

High Report

Rating for KALV

Report

12/4

05:48 am

kalv

Rating for KALV

High Report

Rating for KALV

Report

11/11

07:03 am

kalv

KalVista Pharmaceuticals (NASDAQ:KALV) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..

Medium Report

KalVista Pharmaceuticals (NASDAQ:KALV) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.